Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1998 December; 91(12): 641–643.
PMCID: PMC1296985

Evaluating the return of prostatic adenocarcinoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldstein NS, Bégin LR, Grody WW, Novak JM, Qian J, Bostwick DG. Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon". Am J Surg Pathol. 1995 Sep;19(9):1002–1009. [PubMed]
  • Feneley MR, Chengazi VU, Kirby RS, Nimmon CC, Granowska M, Mather SJ, Ellison D, Granowski AR, Britton KE. Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351. Br J Urol. 1996 Mar;77(3):373–381. [PubMed]
  • Chengazi VU, Feneley MR, Ellison D, Stalteri M, Granowski A, Granowska M, Nimmon CC, Mather SJ, Kirby RS, Britton KE. Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351). J Nucl Med. 1997 May;38(5):675–682. [PubMed]
  • Neal CE, Meis LC. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer. Semin Nucl Med. 1994 Oct;24(4):272–285. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press